BAWEI
837023
Yili Chuanning Biotechnology
301301
Shanghai Menon Animal Nutrition Technology
301156
4
Tongling Jieya Biologic Technology
301108
5
XI'AN WONDER
836419
CN Stock MarketDetailed Quotes
002757 Nanxing Machinery
- 20.04
- -1.30-6.09%
Trading May 15 13:07 CST
5.92BMarket Cap-27.45P/E (TTM)
20.80High19.92Low205.08KlotVolume20.80Open21.34Pre Close414.55MTurnover7.27%Turnover RatioLossP/E (Static)295.46MShares27.5852wk High2.89P/B5.65BFloat Cap10.5852wk Low23.47Limit Up282.05MShs Float28.69Historical High19.21Limit Down4.12%Amplitude4.85Historical Low0.50Dividend TTM20.21Avg Price123.95KlotAsk2.50%Div YieldTTM100Lot Size73.34KlotBid
Nanxing Machinery Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -21.85%755.52M | -7.32%3.75B | -2.54%3.14B | -2.19%2.14B | 3.21%966.81M | 30.50%4.05B | 37.74%3.22B | 40.82%2.19B | 40.69%936.75M | 1.26%3.1B |
| Refunds of taxes and levies | ---- | -9.30%13.06M | -55.44%6.42M | --4.53M | 4,031.44%4.53M | -30.75%14.4M | -26.19%14.4M | ---- | -37.11%109.58K | 392.58%20.79M |
| Cash received relating to other operating activities | -9.29%2.45M | -38.76%17.68M | 114.24%22.57M | -53.01%7.74M | -63.97%2.71M | -28.60%28.86M | -53.63%10.53M | 60.27%16.48M | -0.25%7.51M | -24.70%40.42M |
| Cash inflows from operating activities | -22.18%757.97M | -7.55%3.78B | -2.39%3.17B | -2.36%2.15B | 3.14%974.04M | 29.34%4.09B | 36.34%3.25B | 39.27%2.21B | 40.22%944.37M | 1.34%3.16B |
| Goods services cash paid | -27.08%547.02M | -3.52%2.86B | 2.86%2.38B | 3.09%1.61B | 24.77%750.14M | 22.41%2.96B | 23.94%2.31B | 35.21%1.56B | 16.91%601.21M | 3.55%2.42B |
| Staff behalf paid | -14.59%74.86M | 3.57%328.41M | 3.94%256.11M | 9.05%181.39M | 21.53%87.65M | 9.43%317.09M | 12.28%246.41M | 9.32%166.34M | -0.30%72.12M | -0.00%289.77M |
| All taxes paid | -35.12%29.02M | 8.49%158.48M | 1.25%115.88M | 19.88%87.21M | 61.96%44.73M | 27.80%146.08M | 17.14%114.45M | 9.99%72.75M | -8.47%27.62M | -9.92%114.31M |
| Cash paid relating to other operating activities | 74.93%37M | -14.97%74.91M | 19.81%75.11M | -7.47%44.88M | -9.31%21.15M | 4.14%88.09M | -15.70%62.69M | -4.99%48.5M | -5.97%23.32M | -5.11%84.59M |
| Cash outflows from operating activities | -23.88%687.91M | -2.67%3.42B | 3.28%2.82B | 4.01%1.92B | 24.77%903.68M | 20.80%3.51B | 21.20%2.73B | 29.83%1.85B | 12.89%724.28M | 2.32%2.91B |
| Net cash flows from operating activities | -0.44%70.06M | -37.12%364.78M | -32.71%344.48M | -35.34%230.85M | -68.03%70.37M | 126.32%580.11M | 309.78%511.94M | 123.30%357.04M | 589.44%220.09M | -8.51%256.32M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | ---- | -11.76%1.28M | ---- | ---- | ---- | --1.45M | ---- | ---- | ---- | ---- |
| Cash received from returns on investments | ---- | ---- | ---- | ---- | ---- | -96.75%57.87K | ---- | ---- | ---- | 1,213.20%1.78M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -99.24%2.62K | -75.20%2.32M | -84.53%1.23M | -91.25%554.79K | 6.58%343.35K | 263.85%9.37M | 126,751.60%7.94M | 101,185.78%6.34M | --322.16K | -64.19%2.58M |
| Cash received relating to other investing activities | -31.85%797.66M | 18.99%4.07B | 26.90%3.33B | 39.48%2.29B | 69.01%1.17B | 124.49%3.42B | 133.91%2.63B | 85.23%1.64B | 50.58%692.56M | 76.53%1.52B |
| Cash inflows from investing activities | -31.87%797.66M | 18.72%4.08B | 26.57%3.33B | 38.98%2.29B | 68.98%1.17B | 124.56%3.43B | 134.24%2.63B | 85.57%1.65B | 50.56%692.88M | 75.55%1.53B |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -70.24%13.72M | 55.40%253.06M | 67.96%228.96M | -44.95%64.39M | -14.54%46.12M | -15.47%162.84M | 35.94%136.32M | 88.27%116.96M | 122.91%53.96M | -36.99%192.64M |
| Cash paid to acquire investments | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -100.00%1 |
| Cash paid relating to other investing activities | -36.21%696M | 14.82%4.16B | 21.25%3.28B | 31.89%2.36B | 23.84%1.09B | 126.16%3.62B | 130.03%2.7B | 101.01%1.79B | 50.86%881M | 110.45%1.6B |
| Cash outflows from investing activities | -37.59%709.72M | 16.56%4.41B | 23.49%3.51B | 27.17%2.42B | 21.62%1.14B | 110.96%3.78B | 122.63%2.84B | 100.18%1.9B | 53.72%934.96M | 67.25%1.79B |
| Net cash flows from investing activities | 160.71%87.94M | 4.62%-334.35M | 15.72%-174.11M | 48.52%-132.19M | 113.93%33.73M | -32.38%-350.53M | -36.43%-206.58M | -304.28%-256.77M | -63.55%-242.08M | -31.39%-264.78M |
| Financing cash flow | ||||||||||
| Cash from borrowing | -75.02%28.98M | 243.70%459.9M | 307.80%440.39M | 191.19%314.47M | 257.67%116M | -50.78%133.81M | -11.39%107.99M | 115.99%107.99M | --32.43M | 0.62%271.88M |
| Cash inflows from financing activities | -75.02%28.98M | 243.70%459.9M | 307.80%440.39M | 191.19%314.47M | 257.67%116M | -50.78%133.81M | -11.39%107.99M | 115.99%107.99M | --32.43M | 0.62%271.88M |
| Borrowing repayment | -77.26%12.06M | 499.83%434.62M | 918.44%407.48M | 770.83%294.99M | 186.93%53.02M | -58.48%72.46M | -69.38%40.01M | -70.95%33.87M | -72.92%18.48M | 203.36%174.53M |
| Dividend interest payment | -60.95%4.5M | -40.76%174.41M | -41.11%169.68M | -61.14%75.67M | 5.91%11.53M | 116.77%294.44M | 120.25%288.1M | 53.82%194.75M | 138.30%10.88M | 34.86%135.83M |
| Cash payments relating to other financing activities | -5.16%1.48M | 6.66%23.67M | -8.55%4.67M | -5.37%3.14M | -3.10%1.57M | 33.42%22.19M | 1.46%5.1M | -5.19%3.32M | -18.49%1.62M | 28.80%16.63M |
| Cash outflows from financing activities | -72.71%18.04M | 62.61%632.7M | 74.61%581.82M | 61.16%373.8M | 113.42%66.11M | 18.99%389.09M | 25.02%333.22M | -5.98%231.95M | -58.58%30.98M | 91.04%326.99M |
| Net cash flows from financing activities | -78.08%10.94M | 32.31%-172.79M | 37.21%-141.43M | 52.13%-59.33M | 3,327.51%49.89M | -363.19%-255.28M | -55.71%-225.22M | 36.98%-123.95M | 101.95%1.46M | -155.65%-55.11M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | ---- | -61.64%5.03K | 100.01%0.33 | ---0.03 | ---- | -81.39%13.11K | ---2.97K | ---- | ---- | --70.43K |
| Net increase in cash and cash equivalents | 9.71%168.94M | -454.13%-142.35M | -63.89%28.94M | 266.06%39.33M | 849.92%153.99M | 59.55%-25.69M | 146.82%80.13M | 76.39%-23.68M | 89.24%-20.53M | -135.74%-63.5M |
| Add:Begin period cash and cash equivalents | -29.72%336.59M | -5.09%478.95M | -5.09%478.95M | -5.09%478.95M | -5.08%478.95M | -11.18%504.64M | -11.18%504.64M | -11.18%504.64M | -9.35%504.57M | 45.50%568.14M |
| End period cash equivalent | -20.13%505.53M | -29.72%336.59M | -13.15%507.88M | 7.76%518.28M | 30.76%632.93M | -5.09%478.95M | 47.30%584.76M | 2.81%480.95M | 32.36%484.03M | -11.18%504.64M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership) | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.